316 related articles for article (PubMed ID: 28556385)
41. Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China.
Ma X; Zhao T; Xiao Y; Yu J; Chen H; Huang Y; Liu J; Lin J; Ouyang T
Eur J Pediatr; 2013 May; 172(5):653-9. PubMed ID: 23340697
[TBL] [Abstract][Full Text] [Related]
42. Infantile hemangiomas: what have we learned from propranolol?
Hagen R; Ghareeb E; Jalali O; Zinn Z
Curr Opin Pediatr; 2018 Aug; 30(4):499-504. PubMed ID: 29846253
[TBL] [Abstract][Full Text] [Related]
43. A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension.
Fodor JG; Chockalingam A; Drover A; Fifield F; Pauls CJ
J Clin Pharmacol; 1987 Nov; 27(11):892-901. PubMed ID: 2892865
[TBL] [Abstract][Full Text] [Related]
44. Beta Blockade as Treatment for Intracranial Infantile Hemangioma: Case Report and Literature Review.
Kang E; Friedman N; Mamoun I; Tamburro J; Golden A
Pediatr Neurol; 2016 Jun; 59():13-7. PubMed ID: 27068061
[TBL] [Abstract][Full Text] [Related]
45. Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated?
Liu LS; Sokoloff D; Antaya RJ
Pediatr Dermatol; 2013; 30(5):554-60. PubMed ID: 23829941
[TBL] [Abstract][Full Text] [Related]
46. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
47. Topical propranolol therapy for infantile hemangiomas.
Kunzi-Rapp K
Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
[TBL] [Abstract][Full Text] [Related]
48. A randomized, controlled trial of oral propranolol in infantile hemangioma.
Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
[TBL] [Abstract][Full Text] [Related]
49. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
50. Successful management of airway hemangioma with propranolol.
Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
[TBL] [Abstract][Full Text] [Related]
51. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
52. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
53. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
[TBL] [Abstract][Full Text] [Related]
54. Propranolol for infantile haemangiomas: a review.
Starkey E; Shahidullah H
Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
[TBL] [Abstract][Full Text] [Related]
55. Oral atenolol treatment for infantile hemangiomas: clinical analysis of 133 consecutive patients.
Zhao ZL; Liu C; Wang QZ; Wu HW; Zheng JW
Ann Transl Med; 2021 Jan; 9(2):116. PubMed ID: 33569418
[TBL] [Abstract][Full Text] [Related]
56. Giant cranial and cerebellar hemangioma treated with propranolol.
Benvenisti H; Ben-Sira L; Constantini S; Roth J
Childs Nerv Syst; 2015 May; 31(5):805-8. PubMed ID: 25472450
[TBL] [Abstract][Full Text] [Related]
57. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
[TBL] [Abstract][Full Text] [Related]
58. Successful discontinuation of propranolol for infantile hemangiomas of the head and neck at 12 months of age.
Hong P; Tammareddi N; Walvekar R; Chiu ES; Poole JC; Kluka EA; Simon LM
Int J Pediatr Otorhinolaryngol; 2013 Jul; 77(7):1194-7. PubMed ID: 23706952
[TBL] [Abstract][Full Text] [Related]
59. Topical propranolol for treatment of superficial infantile hemangiomas.
Xu G; Lv R; Zhao Z; Huo R
J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
[TBL] [Abstract][Full Text] [Related]
60. Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period.
Cavalli R; Novotna V; Buffon RB; Gelmetti C
G Ital Dermatol Venereol; 2013 Oct; 148(5):525-30. PubMed ID: 24005146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]